A clinical research study for Parkinson’s Disease (PD)
Summary
A clinical research study to evaluating the safety and effectiveness of an
investigational drug(BIIB122) in study participants diagnosed with early-stage Parkinson’s Disease(PD)
Eligibility
Eligible ages: 30 to 80
Inclusion criteria:
You may be eligible to participate in this trial if you are:
- 30 to 80 years of age
- have been diagnosed with Parkinson’s Disease (PD)
Doctors will also evaluate other criteria to make sure you qualify for the study.
Exclusion criteria:
You may not be eligible to participate in this trial if you:
- have hypersensitivity to BIIB122
- female who is breastfeeding or pregnant
Doctors will also evaluate other criteria to make sure you qualify for the study.
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Please contact Dr. Camila Aquino at (403) 220-8679 or camila.aquino@ucalgary.ca or study coordinator Carolina De La Rosa Jaimes at carolina.delarosa1@ucalgary.ca if you would like to learn more about this trial.
Principal investigator:
Camila Aquino
Clinical trial:
Yes
REB-ID:
REB22-0363